Guan Chao Holdings Limited has announced that its wholly owned subsidiary, BetaMind Investments Limited, has entered into three definitive agreements. These include a Trademark License Agreement, a Lizi Exclusive Authorisation Agreement, and a Jingtai Exclusive Authorisation Agreement. These agreements, effective from May 26, 2025, involve research, development, and commercialization rights related to the compounds XTP-016 and XTP-118. These compounds are crucial for formulating hair growth products, with XTP-118 intended for second-generation product development. The agreements signify a strategic advancement in Guan Chao Holdings' business operations, focusing on enhancing their product offerings in the hair growth market.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。